Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2016 - 2025)
Lemaitre Vascular (LMAT) has disclosed Depreciation & Amortization (CF) for 16 consecutive years, with $2.6 million as the latest value for Q4 2025.
- Quarterly Depreciation & Amortization (CF) rose 7.82% to $2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Dec 2025, up 8.43% year-over-year, with the annual reading at $10.4 million for FY2025, 8.43% up from the prior year.
- Depreciation & Amortization (CF) for Q4 2025 was $2.6 million at Lemaitre Vascular, roughly flat from $2.6 million in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $2.9 million in Q3 2021, with the low at $2.3 million in Q4 2022.
- Average Depreciation & Amortization (CF) over 5 years is $2.5 million, with a median of $2.4 million recorded in 2023.
- The sharpest move saw Depreciation & Amortization (CF) skyrocketed 70.61% in 2021, then dropped 20.67% in 2022.
- Over 5 years, Depreciation & Amortization (CF) stood at $2.9 million in 2021, then dropped by 20.67% to $2.3 million in 2022, then increased by 6.77% to $2.4 million in 2023, then fell by 1.11% to $2.4 million in 2024, then rose by 7.82% to $2.6 million in 2025.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods came in at $2.6 million, $2.6 million, and $2.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.